Skip navigation

News & Events

Keep up to date on AgNovos events and related news

Archive - News

AgNovos Healthcare receives ethics committee approvals for the RESTORE study in Netherlands and Austria

The study titled Randomized Controlled Study of a Local Osteo-Enhancement Procedure (LOEP) to Prevent Secondary Hip Fractures in Osteoporotic Women Undergoing Treatment of Index Hip Fractures (RESTORE) is a randomized, controlled, prospective, single blinded, multi-national study.

New treatment methods for local osteoporotic bone loss - NDR Broadcast with Dr. Müller

The German broadcast channel NDR published a television report about new treatment methods for local osteoporotic bone loss.

AgNovos Healthcare participated at WCO in Paris from April 4th - 7th, 2019

AgNovos Healthcare participated in WCO in Paris from April 4th - 7th, 2019

New Pre-Clinical Data on OSSURE LOEP published in Journal of Orthopedic Research

Current pharmaceutical therapies can reduce hip fractures by up to 50%, but compliance to treatment is low and therapies take up to 18 months to reduce risk. Thus, alternative or complementary approaches to reduce the risk of hip fracture are needed.

LOEP® included in 2019 IOF and ESCEO European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporosis International recently published diagnosis and management guidance from ESCEO and IOF for postmenopausal women with osteoporosis. The publication marks the first time that Local Osteo-Enhancement Procedure has been recognized in this global treatment guidance document.

STRONG Clinical Study Interim Results To Be Presented at the Asia Pacific Orthopedics Association Conference

Dr. Christian Fang delivered a lecture at the Asia Pacific Orthopedics Association conference on April 10th in Antalya, Turkey.